Sivakumar Vijayaraghavalu | Genetics | Research Excellence Award

Published on by Medical Lab Scientist

Dr. Sivakumar Vijayaraghavalu | Genetics | Research Excellence Award

Assistant Professor | Indian Institute of Madras | India

Sivakumar Vijayaraghavalu is an active researcher engaged in translational and interdisciplinary research spanning nanomedicine, cancer biology, epigenetics, gene polymorphisms, drug resistance, and advanced therapeutic delivery systems. His scholarly work emphasizes the integration of molecular and materials-based approaches to address clinically relevant challenges, particularly in oncology and precision therapeutics. He has authored 51 scientific documents published in peer-reviewed journals, reflecting sustained research productivity and methodological breadth. These publications have garnered 1,331 citations, indicating strong research visibility and impact within the scientific community. With an h-index of 17, his body of work demonstrates consistent citation performance and enduring relevance. Collectively, his research contributions have advanced knowledge in epigenetic nanotherapeutics, nano-enabled diagnostics, and targeted treatment strategies, underscoring a focused commitment to generating impactful evidence that supports the translation of basic science discoveries into clinically applicable solutions.

Citation Metrics (Scopus)

1400
1050
700
350
0

1331
Citations

51
Documents

17
h-index

Citations

Documents

h-index

Featured Publications

Heming Li | Molecular Biology | Research Excellence Award

Published on by Medical Lab Scientist

Dr. Heming Li | Molecular Biology | Research Excellence Award

Doctor | The first hospital of China Medical University | China

Dr. Heming Li is an oncology clinician-scientist whose research has generated 1,045 citations across 37 scientific documents with an h-index of 17, reflecting a sustained impact on translational cancer science. His work centers on liquid biopsy innovations, particularly circulating tumor cells (CTCs), tumor invasion and metastasis, and immunotherapy biomarkers in lung, gastric, and hepatobiliary cancers. Dr. Li is recognized for pioneering one of China’s earliest and most sensitive cell-surface vimentin (CSV)–based CTC detection platforms, integrating negative and positive enrichment to enhance diagnostic accuracy, reduce costs, and enable real-time monitoring of tumor evolution. His research spans EMT regulation, immune escape, metabolic reprogramming, and multi-omics characterization of metastatic pathways, leading to first-author and corresponding-author publications in high-impact journals such as The Lancet, Journal of Hematology & Oncology, Journal of Experimental & Clinical Cancer Research, Molecular Cancer, Cancer Letters, and Cell Death & Disease. He has elucidated mechanisms including IGF-IR signaling, KDM4A/STAT3-driven tumor progression, ICAM-1-mediated microenvironmental adaptation, and PD-L1 expression on CSV⁺ CTCs as a prognostic marker in gastric cancer. His recent studies have also advanced understanding of FGL1 as an immune checkpoint target and the biological significance of TROP2 in cancer therapeutics. As principal investigator, he has secured major national and provincial funding, including NSFC General and Young Programs, to study CTC-based biomarkers, immunotherapy prediction models, and metastasis-driving pathways. Through sustained contributions across liquid biopsy technology, molecular oncology, and clinically actionable biomarker development, Dr. Li has established a leading research profile shaping the future of precision cancer care.

Profile: Scopus  

Featured Publications

Deyin Zhang | Genetics | Editorial Board Member

Published on by Medical Lab Scientist

Dr. Deyin Zhang |  Biochemistry | Editorial Board Member

Post Doctor | Lanzhou University | China

Dr. De-yin Zhang is an emerging scholar whose scientific contributions encompass 790 citations, 72 documents, and an h-index of 16, reflecting significant impact in the fields of animal genomics and functional regulatory biology. His work spans comprehensive epigenome mapping, structural genomic analysis, and molecular mechanisms underlying economically important traits in sheep, including feed efficiency, tail-fat deposition, growth performance, and rib number variation. As a doctoral and postdoctoral researcher at Lanzhou University, he has developed expertise in multi-tissue epigenetic atlas construction, genome-wide association studies, whole-genome resequencing, and the characterization of non-coding RNAs, contributing to major publications in high-quality journals such as iMeta, Journal of Integrative Agriculture, Zoological Research, BMC Genomics, and Frontiers in Veterinary Science. His research has revealed novel loci, regulatory elements, and functional mutations associated with key production traits, advancing understanding of both domestication processes and targeted breeding strategies. Dr. Zhang also serves as an ad hoc reviewer for several international journals and has co-led a Frontiers research topic on livestock epigenetics and multi-omics. His scientific excellence has been recognized through competitive grants, including provincial innovation awards and roles in national R&D and NSFC-funded projects focused on feed conversion biology and tail-fat regulatory mechanisms. Through integrative omics approaches and sustained scholarly productivity, Dr. Zhang continues to contribute valuable resources and insights to modern animal genetics and precision livestock breeding.

Profile: Scopus 

Featured Publications

Wenhe Lin | Genetics | Best Researcher Award

Published on by Medical Lab Scientist

Dr. Wenhe Lin | Genetics | Best Researcher Award

Wenhe Lin | University of Chicago | United States

Dr. Wenhe Lin is a researcher affiliated with the Department of Human Genetics at The University of Chicago, United States, whose scientific work focuses on uncovering the genetic and molecular mechanisms that regulate physiological responses to diet and environmental factors. His research contributes to a deeper understanding of how gene expression adapts to metabolic stress, offering insights into the biological foundations of complex diseases. Dr. Lin has published one peer-reviewed article titled “Genetic regulatory effects in response to a high-cholesterol, high-fat diet in baboons,” which appeared in Cell Genomics. This study highlights the interplay between nutrition and genetic regulation, addressing critical questions in metabolic and nutritional genomics. According to his Scopus author profile, Dr. Lin has authored 1 scientific document, which has received 10 citations, and maintains an h-index of 1, reflecting the early yet impactful nature of his academic contributions. His research approach integrates genomic sequencing, bioinformatics, and systems biology to explore gene–environment interactions that influence disease susceptibility. At The University of Chicago, he continues to advance research in human genetics with an emphasis on precision health and individualized nutrition strategies. Dr. Lin’s emerging body of work demonstrates strong potential to shape future investigations into metabolic regulation, genetic variability, and their implications for personalized medicine and human health.

Profiles: ORCID | Scopus | Google Scholar

Featured Publications